Accredited Continuing Education

Accreditation Statement  

The Society for Cardiovascular Angiography and Interventions is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation 

The Society for Cardiovascular Angiography and Interventions designates this live activity for a maximum of 11.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM Maintenance of Certification 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.25 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurses and Radiology Technologists  

This educational activity is pending approval by the Cardiovascular & Pulmonary Continuing Education (CaPCE) for up to 11 contact hours of accredited education. Provider approved by the California Board of Registered Nursing, Provider Number CEP1531.

Successful Completion 

Pick up your conference badge, attend the conference, and complete the post-activity evaluation to obtain credit. 

Acknowledgment of Commercial Support 

This activity is supported by an unrestricted educational grant from Abiomed. SCAI has received in-kind support from Abiomed, Asahi, B. Braun, Cordis, FUJIFILM Sonosite, Inc, Teleflex, and Terumo.


Individuals in control of content reported the following relevant financial relationships with ineligible companies during the content development process for this activity. All relevant financial relationships will be mitigated before the start of the activity. A complete list of disclosures will be available in the conference app.


Alexander Truesdell: Abiomed - Stocks, Consulting, Speaker. Shockwave – Stocks 
Perwaiz Meraj: Abiomed and Cardiovascular Systems, Inc. - Advisory Board 
M. Baber Basir: Abiomed - Principal Investigator, Consulting. ZOLL - Principal Investigator, Consulting. Abbott Vascular, Chiesi, Cardiovascular Systems, Inc., Saranaz – Consulting.

Planning Reviewer

David Cox: No financial relationships with ineligible companies.

Nurse Reviewer

Carolyn Rosner, RN: No financial relationships with ineligible companies. 

SCAI's Independent Content

As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society's policy to ensure balance, independence, objectivity, and scientific rigor in all its activities.

Planning Process

SCAI activities are developed by the SCAI Planners prior to and independent of commercial support. As planners had relevant financial relationships, the agenda was peer reviewed by a member with no relevant financial relationships.

Mitigation of Relevant Financial Relationships

All participating planners, reviewers, faculty, and staff are required to disclose to SCAI all financial relationships with ineligible companies. SCAI identifies relevant financial relationships and mitigates them before the activity begins.

Content Validation Statement

SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations. All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis.

SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients.

SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company.

SCAI's educational content is free of marketing or sales of products or services. Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education.

SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention and where appropriate in the content.



Phone: 800-992-7224